A consistent finding among studies is the reduced levels of p53 in various human clinical specimens, cancer cell lines, and animal model tissues from individuals who carry the rs78378222[A/C] variant in a heterozygous state (Macedo et al., 2016; Deng et al., 2019; Zhang et al., 2021). Here, TP53 is linked to cancer.